Business
Announcement on Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025 and "Corporate Value and Return Enhancement" Action Plan 2026
Announcement on Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025 and "Corporate Value and Return Enhancement" Action Plan 2026
About this update from Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A
Announcement on Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025 and "Corporate Value and Return Enhancement" Action Plan 2026 The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment